Reports for SANIS HEALTH INC

Company Name

SANIS HEALTH INC

Totals

Shortage reports

445

Actual shortage: 47 (11%)
Anticipated shortage: 15 (3%)
Avoided shortage: 8 (2%)
Resolved: 375 (84%)

Discontinuation Reports

68

To be discontinued: 7 (10%)
Discontinued: 51 (75%)
Reversed: 10 (15%)

Late reports

44 (9%)

Overdue reports

12 (17%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
MOMETASONE 50MCG SPRAY, METERED DOSE Resolved 2023-07-31 2023-08-29 200446
ALFUZOSIN 10MG TABLET (EXTENDED-RELEASE) Resolved 2024-03-27 2024-05-17 223485
CEPHALEXIN 250MG TABLET Resolved 2023-07-14 2024-03-08 198742
CEPHALEXIN 500MG TABLET Resolved 2023-07-14 2023-12-26 198745
DESVENLAFAXINE 100MG TABLET (EXTENDED-RELEASE) Resolved 2024-03-25 2024-04-19 223265

Showing 441 to 445 of 445

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
DULOXETINE 30MG CAPSULE (DELAYED RELEASE) Reversed 2024-02-15 2024-04-23 219618
MORPHINE SR 30MG TABLET (EXTENDED-RELEASE) To be discontinued 2020-04-08 2020-04-08 111518
MORPHINE SR 60MG TABLET (EXTENDED-RELEASE) To be discontinued 2020-04-08 2020-06-03 111521
TERAZOSIN 10MG TABLET To be discontinued 2021-12-16 2021-12-16 151275
TERAZOSIN 1MG TABLET To be discontinued 2021-12-16 2021-12-16 151278
TERAZOSIN 2MG TABLET To be discontinued 2021-12-16 2021-12-16 151281
TERAZOSIN 5MG TABLET To be discontinued 2021-12-16 2021-12-16 151284
DULOXETINE 60MG CAPSULE (DELAYED RELEASE) To be discontinued 2024-02-15 2024-02-15 219591

Showing 61 to 68 of 68